Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00186953
Status:
COMPLETED
Last Update Posted:
2011-09-20
First Post:
2005-09-12
Brief Title:
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Sponsor:
St Jude Childrens Research Hospital
Organization:
St Jude Childrens Research Hospital
Study Overview
Official Title:
Determination of Optimal Dose and Safety Profile of Optison Ultrasound Contrast Agent in Pediatric Solid Tumor Patients
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
St Jude Childrens Research Hospital is studying ways to make ultrasound images clearer - to be able to see blood vessels body structures and tumors better Ultrasound uses sound waves to create pictures allowing doctors and other medical professionals to see inside the body
Researchers are studying a contrast agent like a dye called Optison St Jude Childrens Research Hospital researchers want to learn the best and safest dose of this ultrasound dye
Researchers are studying a contrast agent like a dye called Optison St Jude Childrens Research Hospital researchers want to learn the best and safest dose of this ultrasound dye
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None